Table 3.
The susceptibility patterns to different antimicrobial agents between non-carbapenemase-producing and carbapenemase-producing carbapenem-resistant E. coli isolates.
| Carbapenem-resistant E. coli (%Susceptible) | |||
|---|---|---|---|
| Antimicrobial agents | All (n = 10) |
Non-CP-CREc (n = 7) |
CP-CREc (n = 3) |
| Ceftriaxone | 0 | 0 | 0 |
| Ceftazidime | 0 | 0 | 0 |
| Cefepime | 0 | 0 | 0 |
| Ceftazidime-avibactam | 90 | 100 | 66.7 |
| Amikacin | 90 | 100 | 66.7 |
| Gentamicin | 20 | 14.3 | 33.3 |
| Ciprofloxacin | 50 | 57.1 | 33.3 |
| Pip/Tazo | 0 | 0 | 0 |
| TMP/SMX | 30 | 28.6 | 33.3 |
| Ertapenem | 0 | 0 | 0 |
| Imipenem | 0 | 0 | 0 |
Non-CP-CREc, non-carbapenemase-producing carbapenem-resistant E. coli; CP-CREc, carbapenemase-producing carbapenem-resistant E. coli.